← back to search

Dirk H. Busch

German Center for Infection Research · DE
Area of research
Immunology · Oncology
Research interest
Research interests include T-cell and B-cell Immunology, Immune Cell Function and Interaction, CAR-T cell therapy research, and Immunotherapy and Immune Responses.
h-index
85
citations
26,124
works
491
NIH funding
primary concept
Biology
email

Recent publications

Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory
Nature Immunology 2026cited by 3position: middledoi
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities
Nature Reviews Clinical Oncology 2025cited by 5position: middledoi
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Nature 2024cited by 166position: middledoi
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
Nature Cancer 2024cited by 34position: middledoi
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models
Blood 2024cited by 15position: middledoi
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
Nature Communications 2024cited by 5position: middledoi
Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD
Cell Reports Medicine 2023cited by 27position: lastdoi
Genome-wide screening reveals the genetic basis of mammalian embryonic eye development
BMC Biology 2023cited by 20position: middledoi
CD33-TIM3 Dual CAR T Cells: Enhancing Specificity While Maintaining Efficacy Against AML
Blood 2023cited by 10position: middledoi
Unique roles of co-receptor-bound LCK in helper and cytotoxic T cells
Nature Immunology 2022cited by 53position: middledoi
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer
Cancers 2022cited by 2position: middledoi
High-resolution profiling of neoantigen-specific T cell receptor activation signatures links moderate stimulation patterns to resilience and sustained tumor control
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 1position: middledoi
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
European Journal of Immunology 2021cited by 464position: middledoi
Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection
Immunity 2021cited by 81position: middledoi
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
HemaSphere 2021cited by 52position: middledoi
Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients
Viruses 2021cited by 40position: middledoi
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
Blood Cancer Journal 2021cited by 27position: middledoi
Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
Journal for ImmunoTherapy of Cancer 2021cited by 16position: middledoi
IFN-Gamma Producing Regulatory T Cells Counterbalance T Cell-Mediated Injury to the Intestinal Stem Cell Compartment in Mice and Humans
Blood 2021cited by 2position: middledoi
Spatial and temporal plasticity of neoantigen-specific T-cell responses bases on characteristics associated to antigen and TCR
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 2position: middledoi
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Blood 2020cited by 180position: middledoi
Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection
Nature Immunology 2020cited by 118position: lastdoi
Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in Mice
Journal of Crohn s and Colitis 2020cited by 112position: middledoi
Early emergence of T central memory precursors programs clonal dominance during chronic viral infection
Nature Immunology 2020cited by 65position: middledoi
MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo
Cells 2020cited by 32position: middledoi
Physiological relevance of the neuronal isoform of inositol-1,4,5-trisphosphate 3-kinases in mice
Neuroscience Letters 2020cited by 8position: middledoi
A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The “Triple F” approach supported by Procalcitonin and paired blood and urine cultures
PLoS ONE 2020cited by 7position: middledoi
Abstract PR05: T-cell receptor (TCR)-based immunotherapy in pediatric malignancy: Addressing the challenge of early metastasis and low immunogenicity
Cancer Research 2020cited by 0position: middledoi
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology 2019cited by 983position: middledoi
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
Nature Biomedical Engineering 2019cited by 174position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Angela M. Krackhardt · German Cancer Research Center10 papers (2013–2024)Veit R. Buchholz · Marymount University10 papers (2013–2026)Kilian Schober · Technical University of Munich8 papers (2017–2026)Stefan Burdach · München Klinik8 papers (2016–2022)Uwe Thiel · München Klinik Schwabing8 papers (2016–2022)Günther Richter · German Cancer Research Center8 papers (2015–2020)Matthias Schiemann · Technical University of Munich7 papers (2013–2021)Roland Rad · Molecular Oncology (United States)6 papers (2016–2024)Michael Floßdorf · Technical University of Munich6 papers (2013–2021)Michael Neuenhahn · Technical University of Munich6 papers (2013–2020)Thomas G. P. Grünewald · German Cancer Research Center6 papers (2016–2020)Sebastian Jarosch · Technical University of Munich6 papers (2020–2024)Thomas Höfer · Roche (Switzerland)6 papers (2013–2021)Melanie Thiede · Technical University of Munich6 papers (2016–2022)Eva Bräunlein · German Cancer Research Center6 papers (2016–2024)David Schirmer · München Klinik Schwabing5 papers (2016–2020)A. Kirschner · Technical University of Munich5 papers (2016–2020)Franziska Blaeschke · German Cancer Research Center5 papers (2016–2021)Luka Čičin‐Šain · Medizinische Hochschule Hannover4 papers (2015–2021)Richard Klar · Hikma Pharmaceuticals (Germany)4 papers (2016–2019)